Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M717Revenue (TTM) $M598Net Margin (%)-3.0Altman Z-Score1.3
Enterprise Value $M1,491EPS (TTM) $-0.5Operating Margin %9.9Piotroski F-Score3
P/E(ttm)--Beneish M-Score-2.7Pre-tax Margin (%)-5.1Higher ROA y-yN
Price/Book1.310-y EBITDA Growth Rate %--Quick Ratio1.7Cash flow > EarningsY
Price/Sales1.25-y EBITDA Growth Rate %106Current Ratio2.1Lower Leverage y-yN
Price/Free Cash Flow5.4y-y EBITDA Growth Rate %-54.4ROA % (ttm)-1.2Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-3.3Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M37.2ROIC % (ttm)16.4Gross Margin Increase y-yN

Gurus Latest Trades with LCI

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
LCIKen Fisher 2016-12-31 Sold Out $17.25 - $27.82
($23.08)
$ 19.30-16%Sold Out0
LCIRonald Muhlenkamp 2016-09-30 Reduce-1.24%$24.59 - $36.75
($30.54)
$ 19.30-37%Reduce -33.01%270,930
LCIJoel Greenblatt 2016-09-30 Buy 0.1%$24.59 - $36.75
($30.54)
$ 19.30-37%New holding280,182
LCIKen Fisher 2016-09-30 Buy $24.59 - $36.75
($30.54)
$ 19.30-37%New holding7,650
LCIRonald Muhlenkamp 2016-06-30 Reduce-0.02%$17.52 - $25.9
($21.35)
$ 19.30-10%Reduce -0.54%404,405
LCIDavid Dreman 2016-06-30 Sold Out $17.52 - $25.9
($21.35)
$ 19.30-10%Sold Out0
LCIRonald Muhlenkamp 2016-03-31 Buy 2.98%$17.23 - $40.12
($26.78)
$ 19.30-28%New holding406,600
LCIJoel Greenblatt 2016-03-31 Sold Out -0.49%$17.23 - $40.12
($26.78)
$ 19.30-28%Sold Out0
LCIDavid Dreman 2016-03-31 Buy $17.23 - $40.12
($26.78)
$ 19.30-28%New holding70
LCIJoel Greenblatt 2015-12-31 Reduce-0.11%$34.38 - $48.3
($40.96)
$ 19.30-53%Reduce -19.76%1,121,673
LCIDavid Dreman 2015-12-31 Sold Out $34.38 - $48.3
($40.96)
$ 19.30-53%Sold Out0
LCIJoel Greenblatt 2015-09-30 Reduce-0.16%$41.52 - $62.74
($54.88)
$ 19.30-65%Reduce -19.11%1,397,853
LCIDavid Dreman 2015-09-30 Buy $41.52 - $62.74
($54.88)
$ 19.30-65%New holding367
LCIJoel Greenblatt 2015-06-30 Add0.09%$52.6 - $71.15
($60.12)
$ 19.30-68%Add 11.07%1,728,019
LCIJoel Greenblatt 2015-03-31 Add0.27%$41.29 - $69.82
($56.77)
$ 19.30-66%Add 51.63%1,555,795
LCIJoel Greenblatt 2014-12-31 Add0.25%$40.3 - $57.52
($46.48)
$ 19.30-58%Add 238.24%1,026,029
LCIJoel Greenblatt 2014-09-30 Add0.12%$34.05 - $51.19
($39.77)
$ 19.30-51%Add 749.49%303,345
LCIJoel Greenblatt 2014-06-30 Buy 0.02%$29.62 - $49.76
($39.16)
$ 19.30-51%New holding35,709
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

LCI is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


LCI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
FARBER DAVID10% Owner 2016-12-13Sell6,200$25.29-23.69view
FARBER DAVID10% Owner 2016-12-02Sell3,800$25-22.8view
Landis G. MichaelPrincipal Accounting Officer 2016-09-15Sell4,334$32.3-40.25view
Maher James M.Director 2016-09-01Sell1,478$33.91-43.08view
Landis G. MichaelPrincipal Accounting Officer 2016-08-31Sell6,786$33.41-42.23view
Ehlinger RobertVP and CIO 2016-06-23Sell37,141$25.06-22.98view
Ehlinger RobertVP and CIO 2016-06-20Sell62,859$25.4-24.02view
Ehlinger RobertVP of Logistics and CIO 2016-03-01Sell69,247$25.41-24.05view
PAONESSA ALBERT IIIDirector 2016-02-05Buy2,500$24.57-21.45view
GALVAN MARTIN PVP of Finance & CFO 2016-02-05Buy3,000$24.65-21.7view

Quarterly/Annual Reports about LCI:

News about LCI:

Articles On GuruFocus.com
Lannet's Lopinavir, Ritonavir Approved to Treat HIV in US Jan 05 2017 
Teva: Good Value, Questionable Management? Jan 02 2017 
Integer Investments: Akorn Has 100% Upside Potential Jan 01 2017 
Richard Snow Boosts Kinder Morgan, Cuts Macy's Nov 16 2016 
Snow Capital Management's Top 5 New Buys May 12 2016 
A Short-Term Problem Creates Long-Term Opportunity in Lannett Company Jan 12 2016 
Healthcare Company Lannett Offers Compelling Value Oct 13 2015 
Royce 100 Fund Shareholder Letter Sep 20 2015 
Pharmaceutical Stock Picks For March Mar 04 2015 
Lannett Company Looks Cheap At First Glance; But It Is Actually Much Cheaper Than It Looks Dec 29 2014 

More From Other Websites
LANNETT CO INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Jan 19 2017
Lifshitz & Miller Law Firm Announces Investigation of Ally Financial Inc., Amphastar... Jan 19 2017
Harwood Feffer LLP Announces Investigation of Lannett Company Inc. Jan 13 2017
Bernstein Liebhard LLP Announces That Only Four Days Remain To File A Motion For Lead Plaintiff In A... Jan 13 2017
UPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds Shareholders of Lannett Company, Inc. of a Class... Jan 13 2017
DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Lannett... Jan 13 2017
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Lannett... Jan 12 2017
Deadline in Lawsuit for Investors in Lannett Company, Inc. (NYSE: LCI) Shares Announced by... Jan 11 2017
SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Lannett... Jan 09 2017
LCI SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving... Jan 09 2017
DEADLINE ALERT: Brower Piven Reminds Investors Of The January 17, 2017 Deadline In Class Action... Jan 07 2017
Lannett Co., Inc. – Value Analysis (NYSE:LCI) : January 6, 2017 Jan 06 2017
Lannet's Lopinavir, Ritonavir Approved to Treat HIV in US Jan 05 2017
DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Lannett... Jan 05 2017
Lannett Co., Inc. breached its 50 day moving average in a Bullish Manner : LCI-US : January 5, 2017 Jan 05 2017
EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Lannett Company, Inc.... Jan 03 2017
LCI LOSS NOTICE: Rosen Law Firm Reminds Lannett Company, Inc. Investors of Important January 17... Jan 03 2017
Lannett Announces Approval For Lopinavir And Ritonavir Oral Solution USP, 80 Mg/20 Mg Per mL Jan 03 2017
Lannett Announces Approval For Lopinavir And Ritonavir Oral Solution USP, 80 Mg/20 Mg Per mL Jan 03 2017
LCI INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving... Jan 03 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)